BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24867101)

  • 1. Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27.
    Lu H; Li H; Mao D; Zhu Z; Sun H
    Tumour Biol; 2014 Sep; 35(9):8639-43. PubMed ID: 24867101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).
    Shi H; Gong H; Cao K; Zou S; Zhu B; Bao H; Wu Y; Gao Y; Tang Y; Yu R
    J Neurooncol; 2015 Sep; 124(3):357-64. PubMed ID: 26088461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
    Sun EG; Lee KH; Ko YS; Choi HJ; Yang JI; Lee JH; Chung IJ; Paek YW; Kim H; Bae JA; Kim KK
    Mol Carcinog; 2017 Mar; 56(3):1068-1081. PubMed ID: 27648936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
    Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
    Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition.
    Jiang Y; Meng Q; Qi J; Shen H; Sun S
    Tumour Biol; 2015 Sep; 36(10):7641-7. PubMed ID: 25926384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR signaling-dependent MMP7 modulation.
    Jiang Y; Sun S; Liu G; Yan B; Niu J
    Tumour Biol; 2015 Feb; 36(2):1129-33. PubMed ID: 25330950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization of the Nrdp1 E3 ubiquitin ligase is necessary for efficient autoubiquitination but not ErbB3 ubiquitination.
    Printsev I; Yen L; Sweeney C; Carraway KL
    J Biol Chem; 2014 Mar; 289(12):8570-8. PubMed ID: 24519943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrdp1 is involved in hippocampus apoptosis in cardiopulmonary bypass-induced cognitive dysfunction via the regulation of ErbB3 protein levels.
    Zheng J; Min S; Hu B; Liu Q; Wan Y
    Int J Mol Med; 2019 Apr; 43(4):1747-1757. PubMed ID: 30720051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.
    Hatakeyama J; Wald JH; Rafidi H; Cuevas A; Sweeney C; Carraway KL
    Sci Signal; 2016 Jun; 9(434):ra65. PubMed ID: 27353365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
    Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
    Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1-mediated ErbB3 ubiquitination and degradation.
    Wu Y; Wang L; Bao H; Zou S; Fu C; Gong H; Gao Y; Tang Y; Yu R; Shi H
    J Cell Mol Med; 2016 Mar; 20(3):422-9. PubMed ID: 26612725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1-dependent regulation of p27 determines cell fate in colorectal cancer.
    Hristova NR; Tagscherer KE; Fassl A; Kopitz J; Roth W
    Int J Oncol; 2013 Dec; 43(6):1967-75. PubMed ID: 24141420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
    Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
    Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.
    Ingalla EQ; Miller JK; Wald JH; Workman HC; Kaur RP; Yen L; Fry WH; Borowsky AD; Young LJ; Sweeney C; Carraway KL
    J Biol Chem; 2010 Sep; 285(37):28691-7. PubMed ID: 20628057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.